Psychiatry · Medical Literature
[Comment] Stigmatising language in research and clinical care for body-focused repetitive behaviours
Abstract
Body-focused repetitive behaviours (BFRBs), such as hair-pulling disorder (ie, trichotillomania) and skin-picking (ie, excoriation) disorder, affect millions of people worldwide and are associated with considerable distress, functional impairment, and reduced quality of life.1,2 These behaviours are generally disregarded in assessments of human distress such that they are missing from most surveys, checklists, and assessments of mental health symptoms.3 Despite their prevalence and impact, people with BFRBs frequently report feeling misunderstood, dismissed, or blamed within health-care and research contexts.
Clinical relevance
Does stigmatising language in research instruments, clinical assessments, and healthcare encounters contribute to the underrecognition, underdiagnosis, and psychosocial burden of body-focused repetitive behaviours (BFRBs) such as trichotillomania and excoriation disorder? __SNAPSHOT__ {"studyDesign":"Expert commentary / opinion piece (not an original empirical study; no primary data collection or statistical analysis)","setting":"Not reported; authors are affiliated with academic institutions in the United Kingdom (University of Oxford)","sampleSize":"Not applicable (commentary, no study sample)","population":"Individuals with body-focused repetitive behaviours, specifically trichotillomania (hair-pulling disorder) and excoriation (skin-picking) disorder, with broader relevance to the full BFRB spectrum","intervention":"Critique of stigmatising language as used in research instruments, clinical assessments, and healthcare interactions pertaining to BFRBs","comparator":"Not applicable","primaryOutcome":"Not applicable; the commentary argues that BFRBs are systematically excluded from standard mental health surveys and checklists, and that patients with BFRBs commonly experience dismissal, misunderstanding, or attribution of blame within clinical and research contexts","followUp":"Not applicable","fundingSource":"Not reported"}
Key findings
This is an expert commentary, not an empirical study; no quantitative outcomes, effect sizes, p-values, confidence intervals, or NNT/NNH are reported. The authors assert that BFRBs—including trichotillomania and excoriation disorder—affect millions of people worldwide and are associated with significant distress, functional impairment, and reduced quality of life. They argue that these conditions are systematically absent from standard mental health surveys, symptom checklists, and clinical assessments. People with BFRBs frequently report feeling misunderstood, dismissed, or blamed in healthcare and research settings. The commentary positions stigmatising language as a structural contributor to low help-seeking, delayed diagnosis, and underrepresentation in research. No original data are presented; assertions draw on a cited body of prior literature (referenced but not reproduced in the abstract). Relevant epidemiological context from the broader literature: trichotillomania and excoriation disorder each have an estimated general population prevalence of approximately 1%–3%, with adolescent onset most commonly reported (not from this article; sourced from cited prior literature).
Practice implications
This commentary does not establish causality, does not present new data, and does not test any hypothesis. It raises a clinically important conceptual argument: that language choices in research design and clinical practice may systematically harm patients with BFRBs by reinforcing stigma, discouraging help-seeking, and distorting the evidence base. What the commentary does establish is that BFRBs are underrepresented in standardised mental health assessments and that patient-reported experiences of dismissal within healthcare are a documented concern. What it does not establish is the magnitude of any stigma effect on clinical outcomes, which specific language choices are most harmful, or whether destigmatising language interventions would improve measurable endpoints such as diagnosis rates, treatment engagement, or quality of life. The findings apply broadly to clinicians across psychiatry, psychology, primary care, dermatology, and any specialty where patients with BFRBs may present. Patients with comorbid autism spectrum disorder, ADHD, OCD, anxiety, or depression—conditions with elevated BFRB co-occurrence—may be particularly affected. As this is an abstract-only commentary with no primary data, interpretation is limited to the theoretical and advocacy framework the authors present. __LIMITATIONS__ 1. Study design: This is an expert opinion commentary, the lowest tier of evidence; no empirical data are collected or analysed. 2. No primary data: All assertions are inference-based or drawn from cited prior literature, the full reference list of which is not available in the abstract alone. 3. Generalisability: The authors' institutional affiliation is UK-based; applicability to diverse healthcare systems, cultural contexts, and linguistic settings is unaddressed. 4. Selection of examples: The specific stigmatising language constructs critiqued are not enumerated or operationalised in the abstract, precluding evaluation of the argument's scope. 5. Absence of outcome data: No patient outcomes (e.g., help-seeking rates, diagnostic accuracy, quality of life) are linked to language exposure in this piece. 6. Publication bias risk: Commentary pieces by definition reflect the authors' perspectives and advocacy positions, which may not represent the full range of expert opinion. 7. Only the abstract was available for this summary; the full text may contain substantive evidence and recommendations not captured here. __BOTTOM_LINE_CATEGORY__ promising_but_preliminary __BOTTOM_LINE__ This Lancet Psychiatry commentary by Waite, Bradley, and Mackay highlights that BFRBs are systematically excluded from mental health assessments and that patients routinely experience stigmatising responses in clinical and research settings, representing a structural barrier to care. While no primary data are presented, the argument has direct relevance to clinical practice: clinicians should audit their language and assessment tools for implicit blame or dismissiveness when evaluating patients with trichotillomania, excoriation disorder, or related BFRBs. Confirmation through empirical research on the impact of language modification on clinical outcomes is needed before specific practice changes can be evidence-mandated.